377 related articles for article (PubMed ID: 31913167)
41. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
[TBL] [Abstract][Full Text] [Related]
42. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
[TBL] [Abstract][Full Text] [Related]
43. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
[TBL] [Abstract][Full Text] [Related]
44. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
[TBL] [Abstract][Full Text] [Related]
45. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
[TBL] [Abstract][Full Text] [Related]
46. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Shiomi H; Morimoto T; Hayano M; Furukawa Y; Nakagawa Y; Tazaki J; Imai M; Yamaji K; Tada T; Natsuaki M; Saijo S; Funakoshi S; Nagao K; Hanazawa K; Ehara N; Kadota K; Iwabuchi M; Shizuta S; Abe M; Sakata R; Okabayashi H; Hanyu M; Yamazaki F; Shimamoto M; Nishiwaki N; Imoto Y; Komiya T; Horie M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
Am J Cardiol; 2012 Oct; 110(7):924-32. PubMed ID: 22721575
[TBL] [Abstract][Full Text] [Related]
47. Risk assessment for percutaneous coronary intervention of the unprotected left main coronary artery in a real-world population.
Kayaert P; Desmet W; Sinnaeve P; Adriaenssens T; Coosemans M; Ferdinande B; Dubois C
Acta Cardiol; 2012 Oct; 67(5):503-13. PubMed ID: 23252000
[TBL] [Abstract][Full Text] [Related]
48. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
[TBL] [Abstract][Full Text] [Related]
49. Left main PCI: An observational analysis from large single-centre experience.
Goel PK; Jatain S; Khanna R; Pandey CM
Indian Heart J; 2016; 68(1):36-42. PubMed ID: 26896264
[TBL] [Abstract][Full Text] [Related]
50. Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials.
Bertaina M; De Filippo O; Iannaccone M; Colombo A; Stone G; Serruys P; Mancone M; Omedè P; Conrotto F; Pennone M; Kimura T; Kawamoto H; Zoccai GB; Sheiban I; Templin C; Benedetto U; Cavalcante R; D'Amico M; Gaudino M; Moretti C; Gaita F; D'Ascenzo F
J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):554-563. PubMed ID: 30095584
[TBL] [Abstract][Full Text] [Related]
51. Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry).
D'Ascenzo F; Elia E; Marengo G; Wańha W; González Ferreiro R; Truffa A; Trabattoni D; Figini F; Verardi R; Di Palma G; Infusino F; Pivato C; Ochała A; Omedè P; Milewski M; Estevez R; Raporeiras Roubin S; De Filippo O; Conrotto F; Montefusco A; Gili S; Cortese B; Dusi V; Gallone G; Manfredi R; Mancone M; Biondi Zoccai G; Casella G; Templin C; Stefanini G; Wojakowski W; Sheiban I; De Ferrari GM
Am J Cardiol; 2021 Oct; 156():72-78. PubMed ID: 34325877
[TBL] [Abstract][Full Text] [Related]
52. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
[TBL] [Abstract][Full Text] [Related]
53. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
[TBL] [Abstract][Full Text] [Related]
54. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
[TBL] [Abstract][Full Text] [Related]
55. Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials.
Upadhaya S; Baniya R; Madala S; Subedi SK; Khan J; Velagapudi RK; Bachuwa G
J Card Surg; 2017 Feb; 32(2):70-79. PubMed ID: 28081585
[TBL] [Abstract][Full Text] [Related]
56. Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis.
Staudacher DL; Schmitt C; Zirlik A; Zehender M; Stachon P; Bothe W; Zotzmann V; Bode C; von Zur Muehlen C
Catheter Cardiovasc Interv; 2020 Jul; 96(1):E27-E33. PubMed ID: 31512392
[TBL] [Abstract][Full Text] [Related]
57. Clinical and Angiographic Outcomes Comparison of Patients With Left Main Vs Non-Left Main Bifurcation Lesions Treated With Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.
Vergara R; Valenti R; Migliorini A; Ciabatti M; Grazia De Gregorio M; Taborchi G; Morini S; Rondine R; Martone R; Antoniucci D
J Invasive Cardiol; 2018 Dec; 30(12):443-446. PubMed ID: 30504512
[TBL] [Abstract][Full Text] [Related]
58. Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy.
Lee MS; Shlofmitz E; Kaplan B; Shlofmitz R
J Invasive Cardiol; 2016 Apr; 28(4):147-50. PubMed ID: 27031936
[TBL] [Abstract][Full Text] [Related]
59. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
60. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
